Coverage
-
June 11, 2015
Shareholders of Dutch biotech outfit Prosensa Holding NV urged a New York federal judge Thursday to trigger a reconsideration of their securities class action's dismissal in order to "prevent manifest injustice" to those who lost money when the company's stock dropped following a devastating clinical-trial failure.
1 other articles on this case.
View all »